Curaleaf Holdings (CURLF) Asset Utilization Ratio (2020 - 2024)
Curaleaf Holdings (CURLF) posted quarterly Asset Utilization Ratio of 0.44 for Q4 2024, up 37.25% year-over-year from 0.32 in Q1 2024, and up 34.75% quarter-over-quarter from 0.33 in Q3 2024.
Curaleaf Holdings (CURLF) Asset Utilization Ratio (2020 - 2024) Analysis & Trends
Curaleaf Holdings' Asset Utilization Ratio history runs 5 years deep, the most recent figure standing at 0.44 for Q4 2024.
- In Q4 2024, Asset Utilization Ratio rose 37.25% year-over-year to 0.44; the TTM figure through Dec 2024 stood at 0.44 (up 37.25% YoY), while the FY2025 annual figure was 0.44, down 0.84% from the prior year.
- Asset Utilization Ratio for Q4 2024 stood at 0.44, up from 0.33 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 1.78 in Q4 2022, with the low at 0.25 in Q4 2020.
- The 5-year median for Asset Utilization Ratio is 0.41 (2023), against an average of 0.64.
- The sharpest annual moves came in 2022 and 2023: Asset Utilization Ratio soared 428.08% in 2022, then sank 81.84% in 2023.
- Curaleaf Holdings' Asset Utilization Ratio stood at 0.25 in 2020, then jumped by 139.92% to 0.6 in 2021, then surged by 198.48% to 1.78 in 2022, then tumbled by 81.84% to 0.32 in 2023, then soared by 37.25% to 0.44 in 2024.
- Business Quant data shows CURLF's Asset Utilization Ratio at 0.44 in Q4 2024, 0.33 in Q3 2024, and 0.32 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 0.43 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 0.63 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.47 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 0.45 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.41 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 0.66 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 0.37 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Curaleaf Holdings | 2.51 Bn | 2.42 Bn | 169.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 0.44 |
| Sep 30, 2024 | 0.33 |
| Dec 31, 2023 | 0.32 |
| Sep 30, 2023 | 0.41 |
| Dec 31, 2022 | 1.78 |
| Sep 30, 2022 | 1.73 |
| Jun 30, 2022 | 0.59 |
| Dec 31, 2021 | 0.60 |
| Sep 30, 2021 | 0.33 |
| Jun 30, 2021 | 0.28 |
| Dec 31, 2020 | 0.25 |